DRUG UTILIZATION DATA IN RISK BENEFIT ANALYSES OF DRUGS - SESSION-III - DISCUSSION

被引：0
|
作者：
CROUT, R
WIHOLM, BE
SHAPIRO, S
INMAN, WHW
VESSEY, M
HALL, RC
JONES, JK
CROOKS, J
WADE, OL
SKEGG, D
DUKES
FRIEBEL
HJORT, P
SJOQVIST, F
HEKSTER
BIRKETT
机构：
来源：
ACTA MEDICA SCANDINAVICA | 1984年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：149 / 152
页数：4
相关论文
共 50 条
  • [31] COMPUTER-BASED DRUG-UTILIZATION REVIEW - RISK, BENEFIT, OR BOONDOGGLE
    SOUMERAI, SB
    LIPTON, HL
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (24): : 1641 - 1645
  • [32] ESOPHAGEAL MANOMETRY - METHODS AND VALUE IN SCIENCE AND CLINICAL-PRACTICE .3. DRUG EFFECTS ON ESOPHAGEAL SMOOTH-MUSCLE - SUMMARY AND CONCLUSION - SESSION-III
    BALDI, F
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (09) : S88 - S88
  • [33] FDA’s Benefit–Risk Framework for Human Drugs and Biologics: Role in Benefit–Risk Assessment and Analysis of Use for Drug Approvals
    Leila Lackey
    Graham Thompson
    Sara Eggers
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 170 - 179
  • [34] Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients
    Florence T. Bourgeois
    Karen L. Olson
    Annapurna Poduri
    Kenneth D. Mandl
    Pediatric Drugs, 2015, 17 : 401 - 410
  • [35] Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients
    Bourgeois, Florence T.
    Olson, Karen L.
    Poduri, Annapurna
    Mandl, Kenneth D.
    PEDIATRIC DRUGS, 2015, 17 (05) : 401 - 410
  • [36] FDA's Benefit-Risk Framework for Human Drugs and Biologics: Role in Benefit-Risk Assessment and Analysis of Use for Drug Approvals
    Lackey, Leila
    Thompson, Graham
    Eggers, Sara
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 170 - 179
  • [37] Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies
    Marco Sequi
    Rita Campi
    Antonio Clavenna
    Maurizio Bonati
    European Journal of Clinical Pharmacology, 2013, 69 : 599 - 604
  • [38] Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies
    Sequi, Marco
    Campi, Rita
    Clavenna, Antonio
    Bonati, Maurizio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 599 - 604
  • [39] REVIEW OF DATA CUTS USED AS BASIS FOR STATISTICAL ANALYSES AND DERIVATION OF ADDITIONAL BENEFIT PRESENTED WITHIN GERMAN BENEFIT ASSESSMENTS FOR ONCOLOGICAL DRUGS
    Kuehnast, S.
    Kuerschner, N.
    Leverkus, F.
    VALUE IN HEALTH, 2016, 19 (07) : A762 - A762
  • [40] Therapeutic Drug Monitoring of Antidementia Drugs: A Valid Tool for Successful Individual Benefit/Risk Evaluation
    R. Koeber
    H. H. Kluenemann
    D. Melchner
    E. Haen
    Drug Safety, 2008, 31 : 885 - 885
12345